⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for hscrp

Every month we try and update this database with for hscrp cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.NCT03968419
Non-small Cell ...
Canakinumab
Pembrolizumab
18 Years - Novartis
Oxidative Stress Markers in Open and Laparoscopic Colectomy for CancerNCT00928928
Colorectal Canc...
Open colectomy
laparoscopic co...
- G. Hatzikosta General Hospital
Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary SyndromeNCT01459445
Polycystic Ovar...
Endothelial Dys...
Metformin, Ethi...
15 Years - 35 YearsIuliu Hatieganu University of Medicine and Pharmacy
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC SubjectsNCT03631199
Non-small Cell ...
canakinumab
canakinumab mat...
pembrolizumab
carboplatin
cisplatin
paclitaxel
nab-paclitaxel
pemetrexed
18 Years - Novartis
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: